Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Z-103 single-dose pharmacological study in subjects with zinc deficiency
jRCT2080221593
- Sponsor
- Zeria Pharmaceutical Co., Ltd.
- Start
- Sep 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of polaprezinc in zinc deficiency and Peptic ulcer disease (PUD), sponsored by Zeria Pharmaceutical Co., Ltd.
02
Drugs
polaprezinc
03
Conditions
zinc deficiencyPeptic ulcer disease (PUD)
Beyond the preview
Go deeper on jRCT2080221593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221593.